Micardis, Telmisartan News

Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.

New data show that TWYNSTA A , a once daily, single pill combination of the angiotensin II receptor blocker telmisartan and the calcium channel blocker amlodipine, leads to rapid and sustained blood pressure reductions that can bring most patients with previously uncontrolled hypertension on RAS inhibitor monotherapy to BP goal effectively within 4 ... (more)

Hypertension is a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular events, comorbid diabetes mellitus, microalbuminuria and renal impairment.